TC
CRDL
Tejara Capital’s Cardiol Therapeutics CRDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
3,265,819
+70,829
| +2% | +$96.3K | 2.06% | 14 |
|
|
2025
Q1 | $3.1M | Buy |
3,194,990
+79,553
| +3% | +$77.2K | 1.2% | 23 |
|
|
2024
Q4 | $3.99M | Buy |
3,115,437
+1,344,167
| +76% | +$1.72M | 2.61% | 14 |
|
|
2024
Q3 | $3.51M | Buy |
1,771,270
+49,027
| +3% | +$97.1K | 1.67% | 21 |
|
|
2024
Q2 | $3.48M | Buy |
1,722,243
+77,833
| +5% | +$157K | 1.26% | 29 |
|
|
2024
Q1 | $2.98M | Buy |
1,644,410
+527,734
| +47% | +$955K | 1.09% | 29 |
|
|
2023
Q4 | $942K | Buy |
1,116,676
+471,219
| +73% | +$397K | 0.39% | 47 |
|
|
2023
Q3 | $578K | Buy |
645,457
+148,396
| +30% | +$133K | 0.33% | 50 |
|
|
2023
Q2 | $442K | Buy |
497,061
+56,435
| +13% | +$50.2K | 0.22% | 59 |
|
|
2023
Q1 | $215K | Hold |
440,626
| – | – | 0.11% | 76 |
|
|
2022
Q4 | $225K | Buy |
+440,626
| New | +$225K | 0.13% | 83 |
|